Pfizer’s updated COVID-19 booster was found to be nearly 4 times more efficacious against Omicron in older adults; CDC released more flexible guidelines for clinicians prescribing opioids; Senator Mark Warner released a report offering solutions to cybersecurity threats to the health care sector.
Pfizer and BioNTech said new research suggests their updated COVID-19 booster released in September is nearly 4 times better at boosting antibodies against Omicron in older adults compared with the previous version of the vaccine, The New York Times reported. According to the study, participants 55 years or older who received the new booster had antibody levels 3.8 times higher after 1 month compared with participants who received the original booster. However, the study only included a total of 76 participants. Results of a similar clinical trial conducted by Moderna are expected to be published soon.
The CDC released updated, more flexible guidelines for clinicians to prescribe opioids for both short– and long-term pain, The Washington Post reported. The new guidelines got rid of limits on the number of doses and length of treatment for patients with chronic pain that were suggested in the 2016 version of the CDC opioid guidelines, which aimed to curb liberal prescribing of the drugs and control the opioid epidemic. Misinterpretations of the 2016 guidelines resulted in patients having their medications tapered off or abruptly ended and in insurers and pharmacies setting rigid prescription limits. The updated recommendations are for doctors, nurse practitioners, and others authorized to prescribe opioids, and emphasize the importance of patients’ and caregivers’ decisions on treatment.
Senator Mark Warner, D-Virginia, chairman of the Senate Intelligence Committee, released a report outlining cybersecurity threats to the health care sector, calling it “uniquely vulnerable” to attacks and calling transitions in cybersecurity improvements “painfully slow and inadequate,” The Hill reported. Warner’s report is divided into 3 sections suggesting the US federal government enhance cybersecurity leadership in the health care sector, help the private sector reduce cyber threats, and assist health care providers in responding and recovering from these attacks. The report also recommended establishing a cyber disaster relief program for those affected by cyberattacks, as well as a federal reinsurance program to help insurance companies cover some costs related to cyberattacks.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More